|
Q3 2020
Filed on Nov 16, 2020
|
20,850
|
$8.19 - $21.84
$171K - $455K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
7,255
|
$16.94 - $21.91
$123K - $159K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
149,000
|
$7.61 - $9.0
$1.13M - $1.34M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
16,231
|
$2.38 - $3.52
$38.6K - $57.1K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
11,051
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
12,663
|
$0.56 - $2.09
$7.09K - $26.5K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
11,943
|
$4.81 - $6.73
$57.4K - $80.4K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
45,295
|
$17.41 - $19.89
$789K - $901K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
13,621
|
$10.66 - $13.78
$145K - $188K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
38,314
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
34,239
|
$3.66 - $5.72
$125K - $196K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
13,762
|
$3.46 - $8.39
$47.6K - $115K
|
|
Dicerna Pharmaceuticals Inc
|
Q3 2020
Filed on Nov 16, 2020
|
13,625
|
N/A
|
|
Dime Cmnty Bancshares Inc
|
Q3 2020
Filed on Nov 16, 2020
|
16,047
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
14,000
|
$15.44 - $16.78
$216K - $235K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
75,616
|
$0.8 - $2.33
$60.5K - $176K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
52,050
|
$1.42 - $2.85
$73.9K - $148K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
4,000,000
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
174,007
|
N/A
|
|
Eyepoint Pharmaceuticals Inc
|
Q3 2020
Filed on Nov 16, 2020
|
144,923
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
23,692
|
$22.11 - $30.12
$524K - $714K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
12,980
|
$8.75 - $10.05
$114K - $130K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
17,600
|
$12.77 - $24.67
$225K - $434K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
10,524
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
26,659
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
200,900
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
785,865
|
$1.01 - $3.55
$794K - $2.79M
|
|
Grupo Aval Acciones Y Valore
|
Q3 2020
Filed on Nov 16, 2020
|
18,459
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
47,350
|
$0.62 - $1.0
$29.4K - $47.4K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
67,179
|
$2.6 - $4.17
$175K - $280K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
11,217
|
$8.27 - $9.83
$92.8K - $110K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
16,944
|
$10.02 - $11.97
$170K - $203K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
13,864
|
$2.16 - $4.71
$29.9K - $65.3K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
39,903
|
$37.36 - $41.95
$1.49M - $1.67M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
60,531
|
$70.37 - $77.32
$4.26M - $4.68M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
54,455
|
$111.27 - $124.26
$6.06M - $6.77M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
28,243
|
$53.47 - $60.19
$1.51M - $1.7M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
36,445
|
$172.79 - $199.44
$6.3M - $7.27M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
39,114
|
$70.41 - $81.56
$2.75M - $3.19M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
35,000
|
$311.81 - $359.24
$10.9M - $12.6M
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
30,975
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
97,779
|
N/A
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
10,122
|
$5.09 - $11.07
$51.5K - $112K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
251,900
|
$0.75 - $1.09
$189K - $275K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
11,147
|
$6.52 - $8.94
$72.7K - $99.7K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
11,398
|
$11.18 - $12.83
$127K - $146K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
16,385
|
$2.74 - $4.48
$44.9K - $73.4K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
10,215
|
$1.56 - $2.08
$15.9K - $21.2K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
63,770
|
$1.44 - $2.12
$91.8K - $135K
|
|
|
Q3 2020
Filed on Nov 16, 2020
|
45,554
|
$2.49 - $3.39
$113K - $154K
|
|